Mozart Therapeutics
Kristi Manjarrez currently serves as Vice President of Business Operations at Mozart Therapeutics, Inc. since September 2023. Prior experience includes roles at Alpine Immune Sciences, Inc., where Kristi held the positions of Senior Vice President and Vice President of Clinical Affairs from July 2018 to September 2023. Kristi also worked at Silverback Therapeutics as Vice President of Clinical Operations and Medical + Scientific Affairs, and at VentiRx Pharmaceuticals as Vice President of Clinical Affairs, where strategic leadership was provided in clinical development for small-molecule immunomodulators in oncology and atopic diseases. Early career highlights include pivotal roles at Dendreon Corporation, AAI International (MTRA), and Allergy and Asthma Research Associates, contributing to numerous Phase II–IV clinical trials across various therapeutic areas. Kristi holds a Bachelor of Science degree in Microbiology and Biochemistry from the University of Washington.
This person is not in any teams
Mozart Therapeutics
Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.